Al Hammadi Company for Development and Investment, the owner and operator of hospitals in Riyadh, reported a net profit of SAR 141.3 million for the fiscal year 2015, marking a ten percent increase year-on-year (YOY). The company said the profit rise was bolstered by a 16 percent rise in net revenue and collection of SAR 9.8 million written off debt during Q1-2015.
| Item | 2014 | 2015 | Change |
|---|---|---|---|
| Revenues | 481.96 | 561.33 | 16.5 % |
| Gross Income | 209.11 | 240.24 | 14.9 % |
| Operating Income | 130.95 | 143.57 | 9.6 % |
| Net Income | 128.95 | 141.33 | 9.6 % |
| Average Shares | 160.00 | 160.00 | - |
| EPS (Riyals) | 0.81 | 0.88 | 9.6 % |
The fourth-quarter net profit grew by 6 percent YOY to SAR 35.8 million, thanks to higher revenues. Profit for the period was 29 percent compared to the previous quarter.
| Item | Q4 2014 | Q4 2015 | Change |
|---|---|---|---|
| Revenues | 129.43 | 157.70 | 21.8 % |
| Gross Income | 55.99 | 68.06 | 21.6 % |
| Operating Income | 34.52 | 40.39 | 17.0 % |
| Net Income | 33.71 | 35.75 | 6.0 % |
| Average Shares | 160.00 | 160.00 | - |
| EPS (Riyals) | 0.21 | 0.22 | 6.0 % |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| Q1 2015 | 129.48 | 6.1 % | 50.64 | (7.4 %) | 41.01 | 19.8 % | 0.26 |
| Q2 2015 | 137.36 | 12.9 % | 63.56 | 18.4 % | 36.89 | 3.6 % | 0.23 |
| Q3 2015 | 136.80 | 25.7 % | 57.97 | 29.6 % | 27.69 | 8.9 % | 0.17 |
| Q4 2015 | 157.70 | 21.8 % | 68.06 | 21.6 % | 35.75 | 6.0 % | 0.22 |
| 2015 | 561.33 | 16.5 % | 240.24 | 14.9 % | 141.33 | 9.6 % | 0.88 |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2015 | 41.90 % | 29.13 % | 25.73 % |
| Q2 2015 | 42.55 % | 28.68 % | 25.19 % |
| Q3 2015 | 42.80 % | 29.71 % | 24.29 % |
| Q4 2015 | 42.80 % | 31.06 % | 23.43 % |
| 2015 | 42.80 % | 31.06 % | 23.43 % |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2015 | 160.00 | 0.85 | 0.79 | 8.51 |
| Q2 2015 | 160.00 | 0.86 | 0.80 | 8.27 |
| Q3 2015 | 160.00 | 0.87 | 0.81 | 8.44 |
| Q4 2015 | 160.00 | 0.88 | 0.82 | 8.66 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2015 | 51.53 | 55.54 | 5.14 |
| Q2 2015 | 54.13 | 58.30 | 5.61 |
| Q3 2015 | 44.33 | 47.69 | 4.57 |
| Q4 2015 | 41.63 | 44.73 | 4.24 |
2015
| Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
|---|
| Item | Q4 2015 (e) | Q4 2015 (a) | Change |
|---|---|---|---|
| Average | 35.47 | 35.75 | 0.79 % |
| Item | Q4 2015 (e) | Q4 2015 (a) | Change |
|---|---|---|---|
| Albilad Capital | 36.00 | 35.75 | (0.7) % |
| OSOOL AND BAKHEET | 36.20 | 35.75 | (1.3) % |
| KASB Capital | 37.30 | 35.75 | (4.2) % |
| Alistithmar Capital | 37.60 | 35.75 | (4.9) % |
| AlJazira Capital | 33.70 | 35.75 | 6.1 % |
| Al Rajhi Capital | 32.00 | 35.75 | 11.7 % |
| Current | |
| Market Cap (M Riyal) | 7,512.00 |
| Enterprise Value (EV) (M) | 7,510.11 |
| Shares Outstanding ((M)) | 160.00 |
| EPS ( Riyal) (TTM) | 1.79 |
| Book Value (BV) ( Riyal) | 11.58 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | 26.88 |
| P/E (TTM) | 26.27 |
| Price/book | 4.05 |
| Return on Average Assets (%) (TTM) | 11.1 |
| Return on Average Equity (%) (TTM) | 15.9 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}